Dolcanatide

DB13112InvestigationalProtein Based Therapies

Dolcanatide has been investigated in Exposure.

Mechanism
Curator reviewed
Code names
SP-333

Resolves to

Compound
UNIIWU977T914KCAS1092457-65-2
Targets
P25092GUCY2C

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dolcanatide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In